Applicable Symptoms: Indicated for heart failure caused by decreased myocardial contractility in organic heart disease, including low cardiac output syndrome after open heart surgery, as a short-term supportive therapy.

Applicable Symptoms: It is mainly indicated for severe dyspnea caused by bronchospasm. It can quickly relieve anaphylactic shock caused by drugs, and can also prolong the action time of infiltration anesthetics. It is the primary rescue drug in cardiopulmonary resuscitation for cardiac arrest caused by various reasons.

Applicable Symptoms: 1. It can help increasing blood pressure to treat hypotension during general anesthesia and prevent arrhythmia; and it can also be used to treat hypotension induced by intraspinal block, but with the possibility of reducing cardiac output. 2. It can be used to terminate the onset of paroxysmal supraventricular tachycardia.

Applicable Symptoms: Indicated for shock syndrome caused by myocardial infarction, trauma, endotoxin sepsis, cardiac surgery, renal failure, and congestive heart failure; and for shock events that cannot be rescued by blood volume supplementation, especially for those with oliguria and normal or low peripheral vascular resistance. Since this product can increase cardiac blood output, it is also used for cardiac insufficiency where foxglove and diuretics are ineffective.

Applicable Symptoms: It is mainly indicated for severe dyspnea caused by bronchospasm. It can quickly relieve anaphylactic shock caused by drugs, and can also prolong the action time of infiltration anesthetics. It is the primary rescue drug in cardiopulmonary resuscitation for cardiac arrest caused by various reasons.

Applicable Symptoms: Indicated for blood pressure control in certain acute hypotensive situations (e.g., pheochromocytoma resection, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, sepsis, blood transfusion, and drug adverse reactions). Used as an adjuvant therapy for cardiac arrest and severe hypotension. For the emergency treatment of hypovolemia-induced shock, this product can be used as an adjuvant therapy to achieve blood volume supplementation, so as to help increase blood pressure and temporarily maintain perfusion in cerebral and coronary arteries until the blood volume supplementation takes effect; it can also be used for maintaining blood pressure after cardiopulmonary resuscitation (CPR).

Applicable Symptoms: It is indicated for improvement of the angina pectoris , acute myocardial infarction, and arrhythmia due to coronary heart disease and the myocardial ischemia caused by heart failure, and also used as an adjuvant therapy for viral myocarditis. It is also indicated for improving the symptoms of cerebral hypoxia caused by cerebral infarction and cerebral hemorrhage.

Applicable Symptoms: For the treatment of primary hypertension. The fixed-dose compound preparation of this product is used to treat patients whose blood pressure cannot be adequately controlled by telmisartan alone.

Applicable Symptoms: This product is used for the adjuvant therapy of the following diseases: 1. Cardiovascular diseases, such as viral myocarditis and chronic heart failure. 2. Hepatitis, such as viral hepatitis, sub-acute hepatic necrosis and chronic active hepatitis. 3. Comprehensive treatment of cancer: It can alleviate certain adverse reactions caused by radiotherapy and chemotherapy.

Applicable Symptoms: For treatment of fever and mild to moderate pain.

Applicable Symptoms: Indicated for abatement of fever during acute high fever; and also used for short-term treatment of acute pain, such as headache, migraine, muscle pain, joint pain, and dysmenorrhea.

Applicable Symptoms: As an add-on drug, this product is indicated for the symptomatic treatment of adult patients with stable angina pectoris that are poorly controlled by or intolerant to first-line antianginal therapy.